Navigation Links
Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis
Date:8/16/2011

SPARTANBURG, S.C., Aug. 16, 2011 /PRNewswire/ -- Femasys Inc. and Norgenix Pharmaceuticals, LLC today announced an agreement for exclusive distribution rights in the United States as well as US territories and military bases for Femasys' FemVue™ Saline-Air Device. This FDA cleared device is used to evaluate a woman's fallopian tubes with standard ultrasound, called a Sono HSG. Femasys Inc. is an emerging medical device developer of women's healthcare solutions. Norgenix Pharmaceuticals, LLC, a wholly owned subsidiary of the J M Smith Corporation, is a North American distributor with a world-class sales channel for medical device and pharmaceutical products in the women's health arena. Norgenix is licensed to sell, market, and distribute medical devices and prescription drug products in all 50 US states.

"Our agreement with Norgenix is anticipated to have an immediate and significant impact on our sales expansion efforts as we offer the market an advancement in diagnostic care for an infertile woman," stated Kathy Lee-Sepsick, President & CEO of Femasys Inc. "The Norgenix team is providing us with multiple ready-made relationships; we are excited to ramp our production to meet the numerous opportunities Norgenix has presented."

The FemVue™ Saline-Air Device has been cleared by the FDA for use during diagnostic Sono HSG for fallopian tube evaluations. It creates a consistent alternating pattern of saline and air used as contrast allowing physicians to evaluate a woman's fallopian tubes with existing ultrasound equipment. With the FemVue pattern of saline and air, Sono HSG can be a reliable, cost-effective, convenient, and safe procedure performed quickly by a woman's gynecologist or infertility specialist in the office.

"We are pleased to announce our partnership with Femasys," stated Ken Couch, President of Norgenix Pharmaceuticals, LLC. "Femasys' FemVue device is an innovative product that perfectly aligns with our strategic mission to offer solutions to unmet needs in women's health."

"FemVue is an innovative solution in providing convenient and reliable evaluation of the fallopian tubes to the estimated 10 million women in the United States today, including those struggling with infertility or suffering from female fallopian tube disorders," stated Michael Rackley, COO & Senior Vice President of Norgenix Pharmaceuticals. "We are very optimistic about the potential for FemVue; we expect to expand the market rapidly."

ABOUT FEMASYS INC. | www.femasys.com

ABOUT NORGENIX | www.norgenixpharma.com

Media Contact:
Sims Hammond, 864.580.2350, Sims@LaunchSomething.com


'/>"/>
SOURCE Norgenix Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011
2. Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veterans Administration
3. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
4. 3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
5. NewCardio Announces Financial Results for Its 2011 Second Quarter
6. Dehaier Medical Announces Record Second Quarter 2011 Financial Results
7. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
8. Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results
9. GeoVax Labs, Inc. Announces Second Quarter Financial Results
10. Global Pharm Holdings Group, Inc. Announces Second Quarter 2011 Financial Results
11. Spherix Announces Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... SAN FRANCISCO , May 27, 2016 ... biotechnology company focused on developing products for Regenerative Medicine, Neurology and ... Commissiong will be presenting at two upcoming investor conferences: ... Conference Center, 730 Third Avenue, New York City ... at 3:00pm Marcum MicroCap Conference   ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... 2016 , ... May 26, 2016- In search of the K. Warriors, Shaolin ... of “K Warriors” on June 4, 2016 at Ashbury Hotel and Suites 600 West ... and hosted by Shaolin Institute and sanctioned by KSF (Kungfu Sanda Federation), This is ...
(Date:5/27/2016)... Columbia, SC (PRWEB) , ... May 27, 2016 , ... ... launched a line of classic American timber frame barn kits, which can be found ... are inspired by historic American barn plans, and they highlight the craftsmanship of ...
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated ... regulations. This is the first time that Coolsculpting is being used for for ... six months to ensure they meet the prescribed body-fat standard, measured by the circumference-based ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... trusted name in the pharmaceutical, medical and food industries. Aside from its GMP ... certification (SIC), providing proof of successfully certified products, services and staff. , Validation ...
Breaking Medicine News(10 mins):